IRCCS Azienda Ospedaliero Universitaria di Bologna

  • Address

    Via Albertoni 15, 40138 Bologna

  • Founded

    1592

  • Field

    Assistenza e ricerca nei trapianti e nel paziente critico, gestione medica e chirurgica integrata delle patologie oncologiche

  • Website

    www.aosp.bo.it

  • Email

    direzione.scientifica@aosp.bo.it

  • Phone

    051-214

  • Socials

Scientific director

Prof. Stefano Fanti - Prof. Pier Luigi Zinzani

La direzione scientifica del policlinico Sant'Orsola รจ affidata ai Stefano Fanti (ff) e Pier Luigi Zinzani (ff).

The University Hospital of Bologna IRCCS, Sant’ Orsola Polyclinic, is an integrated organization in the national, regional and local system for health and scientific research, with the main aim of guaranteeing a response to health needs through the provision of highly specialized inpatient and outpatient services and the development of clinical and translational research projects aimed at improving the health of the population.

The IRCCS – AOU in Bologna is a Polyspecialist hospital with a high specialization that extends for 1.8 km with a total gross area of 386,982-metre squares. Currently, every activity develops in 32 pavilions, 23 of which are dedicated to assistance and research activities with a daily presence averaging 20,000 people between patients and operators; it has 1,430 beds and a staff of over 5,000 operators and professionals, including university staff with an agreement.

The Company has been recognized as a Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) with national relevance, with Decree on 19 September 2020 and published in the Official Ministerial Gazette No. 266 of 26 October 2020 as one of the disciplines of “assistance and research in transplants and critical patients” and “integrated medical and surgical management of oncology diseases. “

Recently, the clinical and research activity in oncology and hematology within the Polyclinic has been characterized by a significant increase in the volumes of casuistry treated and the experimentation of highly innovative medical and surgical therapies. Over 500 clinical studies and creative and experimental phase I-II-III-IV diagnosis and therapy programmes are active for treating oncological and hematological diseases in adult and pediatric patients.

The institute is also a reference center for allogeneic transplants in adults and children, is the only regional hub for the administration of therapies with CAR-T cells and is a regional reference center for the treatment of ovarian cancer.

The oncology research within the IRCCS AOU in Bologna is aimed at investigating the most innovative therapeutic approaches in oncology and hematology, with explicit reference to medical, surgical, pharmacological, immunotherapy and radiotherapy treatments:

  • identifying criteria and tools for patient stratification to optimize diagnostic and therapeutic strategies;
  • developing innovative therapeutic approaches with particular reference to new drugs, combining drugs with different molecular targets and the immunotherapy approach with CAR-T cells.

The Associates

Consult the individual files of our Members

  • Founders
  • Ordinaries
  • Partecipants